Sponsor or institution

Clinical trials and research at Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Aleniglipron for adults with overweight/obesity and type 2 diabetes

  A long-term test to see if aleniglipron helps weight loss and blood sugar control in adults who are overweight or obese and have type 2 diabetes.

  Recruiting at 57 sites Phase 3 Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics · Birmingham, Alabama and 73 other locations · NCT07654374

• Aleniglipron for weight management in obesity or overweight with a related condition

  This study tests whether aleniglipron, taken daily, helps people with obesity or overweight plus a weight-related condition lose weight when added to a reduced-calorie diet and more activity, compared with a placebo.

  Recruiting at 13 sites Phase 3 Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics · Birmingham, Alabama and 70 other locations · NCT07654361

Quick answers

How many clinical trials run by Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →